Use of HIV viral load in clinical practice: back to the future

Editorial

M S Saag. Ann Intern Med. 1997.

. 1997 Jun 15;126(12):983-5.

doi: 10.7326/0003-4819-126-12-199706150-00010.

No abstract available

Comment on

Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
Hughes MD, Johnson VA, Hirsch MS, Bremer JW, Elbeik T, Erice A, Kuritzkes DR, Scott WA, Spector SA, Basgoz N, Fischl MA, D'Aquila RT. Hughes MD, et al. Ann Intern Med. 1997 Jun 15;126(12):929-38. doi: 10.7326/0003-4819-126-12-199706150-00001. Ann Intern Med. 1997. PMID: 9182469 Clinical Trial.
Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.
O'Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD. O'Brien WA, et al. Ann Intern Med. 1997 Jun 15;126(12):939-45. doi: 10.7326/0003-4819-126-12-199706150-00002. Ann Intern Med. 1997. PMID: 9182470 Clinical Trial.
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.
Mellors JW, Muñoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, Rinaldo CR Jr. Mellors JW, et al. Ann Intern Med. 1997 Jun 15;126(12):946-54. doi: 10.7326/0003-4819-126-12-199706150-00003. Ann Intern Med. 1997. PMID: 9182471